Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01652170 · ClinicalTrials.gov registry record

The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis

A clinical trial of Acute Appendicitis, sponsored by Venaxis.

Completed
Registry status
2,201
Enrollment target
20
Study locations

NCT01652170: Completed study of Acute Appendicitis, sponsored by Venaxis.

NCT01652170 is a study of Acute Appendicitis that has completed, run by Venaxis. The registered enrollment target is 2,201 participants, above the 343-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (542% higher). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01652170, a study of Acute Appendicitis, has completed, sponsored by Venaxis.

COMPLETED
Registry status
2,201 participants
Enrollment target
20
Study locations

Study Summary

This study will consist of a brief interaction with the subject or parent or guardian to obtain consent, collect a blood sample, medical history, and physical examination of those who meet the inclusion criteria. The blood sample will be tested for the WBC value, as well as processed into plasma in order to compute the APPY1 Test result, which is based on a combination of the WBC value and the plasma MRP 8/14 and CRP concentrations received from the APPY1 Test cassette. There will be a 2-week (14 days +/- 3) follow-up telephone call for those subjects that were discharged from the ED without an appendectomy or diagnosis of acute appendicitis. Use of the APPY1 Test to help identify low risk patients could significantly reduce the use of CT scans in diagnosis of AA, thereby reducing the exposure to ionizing radiation in children, adolescents, and young adults.

Primary Outcome

95% confidence intervals on Sensitivity and Specificity

Conditions Studied

Study Locations (20)

Massachusetts

  • Newton-Wellesley Hospital - Newton
  • Baystate Medical Center - Springfield
  • South Shore Hospital - Weymouth

Ohio

  • Cincinnati Children's Hospital - Cincinnati
  • Cleveland Clinic - Cleveland
  • Nationwide Children's - Columbus

Florida

  • University of Florida, College of Medicine - Jacksonville
  • All Children's Hospital - St. Petersburg

Georgia

  • Emory-Egleston (CHOA) - Atlanta
  • Scottish Rite (CHOA) - Atlanta

Michigan

  • University of Michigan, Mott Children's Hospital - Ann Arbor
  • Spectrum Health System - Grand Rapids

Arizona

  • Phoenix Children's Hosptial - Phoenix

Arkansas

  • Arkansas Children's Hospital - Little Rock

California

  • UC Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 2,201 participants
Start Date 2013-01
Est. Completion 2014-02
Venaxis

1 total trials

What the finished NCT01652170 record still lists

NCT01652170 is an observational study that tracks outcomes without assigning an intervention. Its 2,201 participants enrollment target places it among the larger protocols in the corpus, above the 343-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (542% higher).

The record links to 1 condition, with Acute Appendicitis appearing as the primary indexed condition, and to 0 interventions.

NCT01652170 names 20 study sites across 13 states, led by Massachusetts, Ohio, Florida.

Frequently Asked Questions

What is clinical trial NCT01652170 about?

NCT01652170 is a clinical study titled "The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis". This study will consist of a brief interaction with the subject or parent or guardian to obtain consent, collect a blood sample, medical history, and physical examination of those who meet the inclusion criteria. The blood sample will be tested for the WBC value, as well as processed into plasma in ...

What is the current status of trial NCT01652170?

This trial is currently completed. The enrollment target is 2,201 participants. The study started on 2013-01. Estimated completion is 2014-02.

What conditions does trial NCT01652170 study?

This clinical trial studies the following conditions: Acute Appendicitis.

Who is sponsoring clinical trial NCT01652170?

This trial is sponsored by Venaxis, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01652170 being conducted?

This trial has 20 study locations across Arizona, Arkansas, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Appendicitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05654207 · 2,200 participants · NA

    WeCare: A System of Care for Black Youth

  • NCT06144554 · 2,200 participants

    Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

  • NCT06526988 · 2,200 participants · NA

    Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

  • NCT06682650 · 2,200 participants · NA

    Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01652170, the US trial registry maintained by the National Library of Medicine. NCT01652170 (large enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.